10 results on '"Orlikova H"'
Search Results
2. Spotlight on measles 2010: A measles outbreak in a Roma population in Pulawy, eastern Poland, June to August 2009
- Author
-
Orlikova, H, primary, Rogalska, J, additional, Kazanowska-Zielinska, E, additional, Jankowski, T, additional, Slodzinski, J, additional, Kess, B, additional, and Stefanoff, P, additional
- Published
- 2010
- Full Text
- View/download PDF
3. Mass immunisation campaign in a Roma settled community created an opportunity to estimate its size and measles vaccination uptake, Poland, 2009
- Author
-
Stefanoff, P, primary, Orlikova, H, additional, Rogalska, J, additional, Kazanowska-Zielinska, E, additional, and Slodzinski, J, additional
- Published
- 2010
- Full Text
- View/download PDF
4. PII-2 Active surveillance of aseptic neuroinfections in Poland, 2009.
- Author
-
Stefanoff, P., primary, Lankiewicz, A., additional, Rzepczak, E., additional, Siennicka, J., additional, and Orlikova, H., additional
- Published
- 2009
- Full Text
- View/download PDF
5. Effectiveness of Vaccination Against Tick-Borne Encephalitis in the Czech Republic, 2018-2022.
- Author
-
Kyncl J, Angulo FJ, Orlikova H, Zhang P, Vlckova I, Maly M, Krivohlavkova D, Harper LR, Edwards J, Bender C, Pilz A, Erber W, Madhava H, and Moïsi JC
- Subjects
- Czech Republic epidemiology, Humans, Middle Aged, Adolescent, Adult, Child, Young Adult, Female, Male, Child, Preschool, Aged, Infant, Encephalitis, Tick-Borne prevention & control, Encephalitis, Tick-Borne epidemiology, Vaccination, Viral Vaccines administration & dosage, Encephalitis Viruses, Tick-Borne immunology
- Abstract
Background: Tick-borne encephalitis (TBE) is caused by the tick-borne encephalitis virus (TBEV). TBEV infection can cause symptoms of central nervous system (CNS) inflammation and result in severe consequences including death. TBE is an increasing health threat in the Czech Republic and elsewhere in Europe. In 2020, 23% of 3734 TBE cases reported to the European Centre for Disease Prevention and Control were from the Czech Republic. TBE vaccination is universally recommended in the Czech Republic, but a full analysis of TBE vaccine effectiveness (VE) in the Czech Republic has not been published. Methods: TBE is a notifiable disease in the Czech Republic with mandatory reporting of cases ( i.e., laboratory-confirmed TBEV infected patient with symptoms of CNS inflammation) and vaccination history to public health authorities. TBE VE was estimated using the screening method utilizing public health surveillance data from 2018 to 2022 and online household surveys of the general population on TBE vaccine uptake conducted in 2019-2022. Results: In 2018-2022, 3648 TBE cases were reported in the Czech Republic; 98.1% (3105/3166) of TBE cases with known vaccination history were unvaccinated. Among 42,671 persons surveyed from the general population who had known TBE vaccination history, 66.5% were unvaccinated. VE against TBE was 97.6% (95% confidence interval 95.7-98.7). When stratified by age group, VE was 97.1% (88.4-99.3) in 1-15 years of age, 97.9% (95.3-99.0) in 16-59 years of age, and 96.9% (90.5-99.0) in ≥60 years of age. TBE vaccination averted an estimated 1020 TBE cases in the Czech Republic from 2018 to 2022. Conclusions: This first published study with a full analysis of TBE VE in the Czech Republic showed that vaccination was highly effective for the prevention of TBE including in children, an age group with increasing TBE disease burden. Vaccination averted hundreds of TBE cases and hospitalizations despite the relatively low compliance with TBE vaccine recommendations. To prevent additional TBE cases in the Czech Republic, enhanced efforts to increase TBE vaccine uptake are needed.
- Published
- 2024
- Full Text
- View/download PDF
6. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022.
- Author
-
Vaughan AM, Cenciarelli O, Colombe S, Alves de Sousa L, Fischer N, Gossner CM, Pires J, Scardina G, Aspelund G, Avercenko M, Bengtsson S, Blomquist P, Caraglia A, Chazelle E, Cohen O, Diaz A, Dillon C, Dontsenko I, Kotkavaara K, Fafangel M, Ferraro F, Firth R, Fonager J, Frank C, Carrasco MG, Gkolfinopoulou K, Grenersen MP, Guzmán Herrador BR, Henczkó J, Hoornenborg E, Igoe D, Ilić M, Jansen K, Janță DG, Johansen TB, Kasradze A, Koch A, Kyncl J, Martins JV, McAuley A, Mellou K, Molnár Z, Mor Z, Mossong J, Novacek A, Orlikova H, Pem Novosel I, Rossi MK, Sadkowska-Todys M, Sawyer C, Schmid D, Sîrbu A, Sondén K, Tarantola A, Tavares M, Thordardottir M, Učakar V, Van Ewijk C, Varjas J, Vergison A, Vivancos R, Zakrzewska K, Pebody R, and Haussig JM
- Subjects
- Animals, Child, Disease Outbreaks, Female, Humans, Monkeypox virus, World Health Organization, Exanthema, Mpox (monkeypox) diagnosis, Mpox (monkeypox) epidemiology
- Abstract
Following the report of a non-travel-associated cluster of monkeypox cases by the United Kingdom in May 2022, 41 countries across the WHO European Region have reported 21,098 cases and two deaths by 23 August 2022. Nowcasting suggests a plateauing in case notifications. Most cases (97%) are MSM, with atypical rash-illness presentation. Spread is mainly through close contact during sexual activities. Few cases are reported among women and children. Targeted interventions of at-risk groups are needed to stop further transmission.
- Published
- 2022
- Full Text
- View/download PDF
7. The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation.
- Author
-
Stock NK, Maly M, Sebestova H, Orlikova H, Kozakova J, and Krizova P
- Subjects
- Biostatistics, Czech Republic epidemiology, Epidemiological Monitoring, Follow-Up Studies, Humans, Immunization Programs statistics & numerical data, Immunization Schedule, Incidence, Mass Vaccination statistics & numerical data, National Health Programs statistics & numerical data, Pneumococcal Infections prevention & control, Pneumococcal Vaccines administration & dosage, Vaccines, Conjugate administration & dosage, Pneumococcal Infections epidemiology
- Abstract
Background: Invasive pneumococcal disease (IPD) is caused by Streptococcus pneumoniae and mostly presents as pneumonia, sepsis or meningitis. A notable portion of IPD cases is vaccine preventable and the pneumococcal conjugate vaccine (PCV) was introduced into the routine childhood immunization programs in many countries during the last decades., Objectives: Before PCV introduction in the Czech Republic in 2010, a national surveillance system for IPD was implemented in 2008 and further improved in 2011. In this study, we describe the new surveillance system for the first time and measure its sensitivity between 2010 and 2013 using the capture-recapture method. Furthermore, we describe the recent epidemiological trend of IPD, taking sensitivity estimates into account., Results and Conclusions: Between 2010 and 2013 the estimated sensitivity of the overall IPD surveillance increased from 81% to 99%. The sensitivity of individual reporting sources increased from 72% to 87% for the laboratory system and from 31% to 89% for the epidemiological notification system. Crucial for this improvement was the introduction of quarterly report reminders in 2011. Due to positive source dependency, the presented sensitivity estimates are most probably overestimated and reflect the upper limit of reporting completeness. Stratification showed variation in sensitivity of reporting particularly according to region. An effect of the PVC vaccination in the Czech Republic is visible in the incidence of IPD in target age groups (<5 y). This influence was not evident in the total IPD incidence and may interfere with increasing sensitivity of reporting. In 2013, an increase in the IPD incidence was observed. This finding requires further observation and a detailed vaccine impact analysis is needed to assess the current immunization strategy.
- Published
- 2015
- Full Text
- View/download PDF
8. New endemic foci of tick-borne encephalitis (TBE) identified in districts where testing for TBE was not available before 2009 in Poland.
- Author
-
Stefanoff P, Zielicka-Hardy A, Hlebowicz M, Konior R, Lipowski D, Szenborn L, Siennicka J, and Orlikova H
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Epidemiological Monitoring, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Poland epidemiology, Risk, Young Adult, Antibodies, Viral blood, Encephalitis Viruses, Tick-Borne immunology, Encephalitis, Tick-Borne epidemiology
- Abstract
Background: Tick-borne encephalitis (TBE) is found in limited endemic foci in Poland. Lack of diagnosis limits disease detection in non-endemic provinces., Methods: In 2009, we enhanced TBE surveillance to confirm the location of endemic foci and inform vaccination policy. In 105 hospitals located in 11/16 provinces, we identified suspected TBE cases through admission ICD-10 codes indicating aseptic meningo-encephalitis or from specimens tested for TBE. The National Reference Laboratory confirmed cases at no cost, by testing serum and/or cerebrospinal fluid using ELISA method. We calculated TBE reported rates as the number of confirmed TBE cases per 100,000 inhabitants. Adjusting to neighbouring districts, we classified districts as non-endemic (<0.1 cases per 100,000 inhabitants), low endemic (> = 0.1 to <1), moderately endemic (> = 1 to <5) and highly endemic (> = 5). We compared surveillance data obtained in 2009 with 2004-2008 baseline data., Results: Among 166,099 admissions, we identified 1,585 suspected TBE cases of which 256 were confirmed. Physicians reported more suspected cases among patients <40 years old (12 cases per 1,000 admissions) than among older patients (8 cases per 1,000 admissions). However, patients <40 years of age were confirmed less frequently (16%), than older patients (35%). Physicians reported more suspected cases in districts classed as endemic during 2004-2008 (12 cases per 1,000 admissions, 77% tested for TBE) than in districts classed as non-endemic (7 cases per 1,000 admissions, 59% tested). Of the 38 newly identified endemic districts, 31 were adjacent to 2004-2008 endemic districts and 7 were isolated., Conclusions: Enhanced surveillance detected 38 new endemic districts to be considered for TBE vaccination. However, lack of consistent testing in districts believed to be TBE-free remained an obstacle for mapping TBE risk. Although the disease affects mostly older adults and the elderly, more attention is given to the diagnosis of TBE in young patients. Solutions need to be identified to sustain sensitive, acceptable and affordable TBE surveillance in all districts of Poland. Also, higher attention should be given to the diagnosis of TBE in the elderly.
- Published
- 2013
- Full Text
- View/download PDF
9. [Mumps in Poland in 2009].
- Author
-
Paradowska-Stankiewicz I and Orlikova H
- Subjects
- Adolescent, Adult, Age Distribution, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Mass Vaccination statistics & numerical data, Measles-Mumps-Rubella Vaccine administration & dosage, Mumps prevention & control, Poland epidemiology, Rural Population statistics & numerical data, Urban Population statistics & numerical data, Child Welfare statistics & numerical data, Mumps epidemiology, Registries statistics & numerical data
- Abstract
In 2009, 2.954 cases of mumps were reported In Poland. Decreasing trend in number of cases and incidence has continued. The incidence 7.7 per 100 000 in 2009 was lower compared to the previous year (8.6) and twenty-five times less than the median incidence in 2003-2007. Children 5-9 year old were the most affected age group -56.7 per 100 000. Of 2.954 cases 35 were hospitalized i.e. 1.18%. In 2009 no deaths attributed to mumps were reported.
- Published
- 2011
10. [Mumps in Poland in 2008].
- Author
-
Paradowska-Stankiewicz I and Orlikova H
- Subjects
- Adolescent, Adult, Age Distribution, Child, Child, Preschool, Female, Humans, Incidence, Infant, Male, Mass Vaccination statistics & numerical data, Middle Aged, Mumps prevention & control, Poland epidemiology, Risk Factors, Rural Population statistics & numerical data, Urban Population statistics & numerical data, Child Welfare statistics & numerical data, Measles-Mumps-Rubella Vaccine administration & dosage, Mumps epidemiology, Registries statistics & numerical data
- Abstract
In 2008, 3.271 cases of mumps were reported In Poland. The incidence 8.6 per 100 000 was lower compared to the last year (10.9) and twenty times less than the median incidence in 2002-2006. Children 5-9 year old were the most affected age group - 67.0 per 100 000. Of 3 271 cases 37 were hospitalized. In 2008 no deaths attributed to mumps were reported.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.